Hypogonadism Explained: The Clinical Term for Low Testosterone

If a doctor has mentioned the word "hypogonadism" in a recent conversation about your health, it can sound alarming — a clinical-sounding term for something most people just call "low T." This guide explains what hypogonadism actually means, the difference between the clinical and colloquial usage, the types doctors distinguish between, and what diagnosis and management look like in Singapore.

For a broader picture, see our complete guide to low testosterone.

1What hypogonadism actually means

Hypogonadism is the clinical term for a condition in which the body doesn't produce enough sex hormones. In men, it refers specifically to inadequate testosterone production. The Endocrine Society defines male hypogonadism as the combination of consistently low serum testosterone on at least two morning blood tests, together with consistent clinical symptoms.

The two-criteria definition matters. A low testosterone level alone, without symptoms, is not typically diagnosed as hypogonadism. Symptoms alone, without confirmed low testosterone on testing, is also not hypogonadism — even if those symptoms overlap with the typical hypogonadism picture.

2The two main types: primary and secondary

Doctors classify hypogonadism by where in the body the problem originates.

Primary hypogonadism (also called hypergonadotropic hypogonadism) means the testes themselves cannot produce enough testosterone, even though the brain is sending normal signals. On blood tests, this shows up as low testosterone with high LH and FSH — the brain is calling louder but not getting a response.

Secondary hypogonadism (also called hypogonadotropic hypogonadism) means the signals from the brain to the testes are not getting through. The testes themselves could produce testosterone if asked, but they aren't being asked. On blood tests, this shows up as low testosterone with low or inappropriately normal LH and FSH.

The distinction matters for two reasons. First, the workup differs — primary hypogonadism may point to testicular causes (imaging, sometimes genetic testing), while secondary hypogonadism points upstream (prolactin, pituitary imaging, thyroid). Second, in some cases of secondary hypogonadism, treating the underlying upstream cause can restore normal testosterone production without long-term replacement.

3Late-onset hypogonadism (LOH)

A third category sits between the two: late-onset hypogonadism, sometimes called andropause. This refers to the gradual, age-related decline in testosterone that becomes clinically significant in some older men. The mechanism is mixed — testicular function declines with age, and pituitary signalling becomes less robust, so it has features of both primary and secondary forms.

Late-onset hypogonadism is the most common type of hypogonadism in men over 50. Our article on andropause vs low testosterone covers this in detail.

4How hypogonadism is diagnosed in Singapore

The Endocrine Society guidelines, which Singapore clinicians broadly follow, recommend:

1. 1Confirmed low testosterone on two separate morning blood tests (typically 7–10am). Day-to-day variation is real and a single result is not sufficient.
2. 2Clinical symptoms consistent with hypogonadism (low libido, fatigue, erectile difficulties, reduced muscle, mood changes, etc.).
3. 3Additional testing to establish whether it is primary or secondary — typically LH, FSH, prolactin, and a comprehensive review.
4. 4Targeted further investigation based on those results — thyroid function, pituitary imaging, genetic testing, or imaging of the testes, as clinically indicated.

For more on the testing process, see our guide to testosterone testing in Singapore and how to read your results.

5How hypogonadism is managed

Management depends on the cause and the symptoms. Broadly:

• Address reversible contributors first — sleep, weight, medications, alcohol, untreated conditions.
• Treat the underlying cause where possible — for example, treating a prolactin-secreting pituitary tumour, stopping a medication that suppresses testosterone, or treating sleep apnoea.
• Testosterone replacement therapy (TRT) for men with confirmed hypogonadism and significant symptoms where reversible causes have been addressed and replacement is appropriate. TRT in Singapore is available as injection or topical gel; it is prescription-only and regulated by HSA.
• Ongoing monitoring — typically a re-check at 6 weeks after starting treatment, then at 3 months, then every 6–12 months.

6Frequently asked questions

Is hypogonadism the same as low testosterone?

Closely related but not identical. Hypogonadism is the clinical diagnosis: confirmed low testosterone plus symptoms. "Low T" is a more colloquial term that can refer to any low testosterone result, with or without symptoms.

Can hypogonadism be cured?

Sometimes — if there's a reversible cause (a medication, severe obesity, untreated sleep apnoea, or a treatable pituitary issue), addressing that may restore normal testosterone. For most cases of age-related hypogonadism, ongoing management is the realistic frame.

Does hypogonadism affect fertility?

Yes, hypogonadism is commonly associated with reduced sperm production and can affect fertility. Importantly, TRT itself further suppresses sperm production, so men who wish to have children should discuss alternatives with their doctor before starting testosterone replacement.

Is hypogonadism a permanent condition?

It depends on the type and cause. Primary hypogonadism (testicular) is usually permanent. Secondary hypogonadism due to a reversible cause may resolve. Age-related (late-onset) hypogonadism is typically managed long-term rather than cured.

7Speak to a doctor on Noah

If you have been told you have hypogonadism or low testosterone and want to discuss the diagnosis, the cause, or next steps, you can book a confidential consultation with a Singapore-licensed doctor on Noah.

8References

Bhasin S, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. JCEM. 2018;103(5):1715–1744.

Wu FCW, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. NEJM. 2010;363(2):123–135.

Mulhall JP, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. 2018 (updated 2023).

Articles on Noah are for informational purposes only and do not replace medical advice from a qualified doctor. To consult on Noah, click here. Noah's editorial standards are described on our editorial standards page.